Class information for:
Level 1: UROKINASE RECEPTOR//UPAR//UPA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
458 3413 46.0 84%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
111 3       THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY 71244
2572 2             UROKINASE RECEPTOR//UPAR//UPA 3695
458 1                   UROKINASE RECEPTOR//UPAR//UPA 3413

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UROKINASE RECEPTOR authKW 1362640 6% 81% 188
2 UPAR authKW 1024328 6% 59% 195
3 UPA authKW 650072 5% 39% 187
4 UROKINASE authKW 478326 7% 21% 253
5 UROKINASE TYPE PLASMINOGEN ACTIVATOR authKW 452323 4% 36% 141
6 UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR authKW 331931 2% 62% 60
7 FINSEN address 286423 5% 19% 172
8 SUPAR authKW 258464 1% 57% 51
9 UROKINASE PLASMINOGEN ACTIVATOR authKW 256926 2% 35% 82
10 PLASMINOGEN ACTIVATOR authKW 255444 5% 15% 187

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 12800 33% 0% 1110
2 Hematology 4032 11% 0% 380
3 Cell Biology 2733 16% 0% 548
4 Biochemistry & Molecular Biology 1537 21% 0% 726
5 Peripheral Vascular Diseases 1378 7% 0% 225
6 Medicine, Research & Experimental 489 6% 0% 192
7 Pathology 423 4% 0% 131
8 Medical Laboratory Technology 237 2% 0% 56
9 Biophysics 193 4% 0% 132
10 Dermatology 141 2% 0% 71

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FINSEN 286423 5% 19% 172
2 SPECIALTY CARE SERV 61871 0% 43% 16
3 COPENHAGEN BIO 36261 1% 16% 25
4 C6 35776 0% 67% 6
5 EXPT SURG MOL ONCOL SOLID TUMORS 35768 0% 40% 10
6 SECT 3735 33709 0% 54% 7
7 DANISH CHINESE PROTEASES CANC 30651 0% 29% 12
8 MOL PATHOL MED 29237 0% 30% 11
9 CHARITE FRANZ VOLHARD CLIN 28622 0% 80% 4
10 CANC BIOL PHARMACOL 23271 1% 11% 24

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FIBRINOLYSIS 44884 2% 9% 57
2 FIBRINOLYSIS & PROTEOLYSIS 10477 0% 7% 17
3 CLINICAL & EXPERIMENTAL METASTASIS 5432 1% 2% 35
4 INTERNATIONAL JOURNAL OF CANCER 5211 3% 1% 110
5 THROMBOSIS AND HAEMOSTASIS 4933 2% 1% 75
6 CANCER RESEARCH 4883 4% 0% 149
7 INVASION & METASTASIS 3426 0% 3% 13
8 CANCER COMMUNICATIONS 3146 0% 6% 6
9 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 2845 0% 2% 17
10 ENZYME & PROTEIN 2475 0% 6% 5

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 UROKINASE RECEPTOR 1362640 6% 81% 188 Search UROKINASE+RECEPTOR Search UROKINASE+RECEPTOR
2 UPAR 1024328 6% 59% 195 Search UPAR Search UPAR
3 UPA 650072 5% 39% 187 Search UPA Search UPA
4 UROKINASE 478326 7% 21% 253 Search UROKINASE Search UROKINASE
5 UROKINASE TYPE PLASMINOGEN ACTIVATOR 452323 4% 36% 141 Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR
6 UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR 331931 2% 62% 60 Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR+RECEPTOR Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR+RECEPTOR
7 SUPAR 258464 1% 57% 51 Search SUPAR Search SUPAR
8 UROKINASE PLASMINOGEN ACTIVATOR 256926 2% 35% 82 Search UROKINASE+PLASMINOGEN+ACTIVATOR Search UROKINASE+PLASMINOGEN+ACTIVATOR
9 PLASMINOGEN ACTIVATOR 255444 5% 15% 187 Search PLASMINOGEN+ACTIVATOR Search PLASMINOGEN+ACTIVATOR
10 UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR 251291 1% 59% 48 Search UROKINASE+PLASMINOGEN+ACTIVATOR+RECEPTOR Search UROKINASE+PLASMINOGEN+ACTIVATOR+RECEPTOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ANDREASEN, PA , KJOLLER, L , CHRISTENSEN, L , DUFFY, MJ , (1997) THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER METASTASIS: A REVIEW.INTERNATIONAL JOURNAL OF CANCER. VOL. 72. ISSUE 1. P. 1-22 226 71% 1159
2 MEKKAWY, AH , POURGHOLAMI, MH , MORRIS, DL , (2014) INVOLVEMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER: AN OVERVIEW.MEDICINAL RESEARCH REVIEWS. VOL. 34. ISSUE 5. P. 918 -956 229 74% 25
3 ULISSE, S , BALDINI, E , SORRENTI, S , D'ARMIENTO, M , (2009) THE UROKINASE PLASMINOGEN ACTIVATOR SYSTEM: A TARGET FOR ANTI-CANCER THERAPY.CURRENT CANCER DRUG TARGETS. VOL. 9. ISSUE 1. P. 32 -71 271 55% 144
4 BOONSTRA, MC , VERSPAGET, HW , GANESH, S , KUBBEN, FJGM , VAHRMEIJER, AL , DE VELDE, CJHV , KUPPEN, PJK , QUAX, PHA , SIER, CFM , (2011) CLINICAL APPLICATIONS OF THE UROKINASE RECEPTOR (UPAR) FOR CANCER PATIENTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 19. P. 1890-1910 216 79% 14
5 SMITH, HW , MARSHALL, CJ , (2010) REGULATION OF CELL SIGNALLING BY UPAR.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 11. ISSUE 1. P. 23 -36 122 71% 331
6 CARRIERO, MV , STOPPELLI, MP , (2011) THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR AND THE GENERATION OF INHIBITORS OF UROKINASE ACTIVITY AND SIGNALING.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 19. P. 1944 -1961 180 76% 22
7 BLASI, F , SIDENIUS, N , (2010) THE UROKINASE RECEPTOR: FOCUSED CELL SURFACE PROTEOLYSIS, CELL ADHESION AND SIGNALING.FEBS LETTERS. VOL. 584. ISSUE 9. P. 1923 -1930 108 92% 129
8 ARCHINTI, M , BRITTO, M , EDEN, G , FURLAN, F , MURPHY, R , DEGRYSE, B , (2011) THE UROKINASE RECEPTOR IN THE CENTRAL NERVOUS SYSTEM.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 10. ISSUE 2. P. 271 -294 205 60% 7
9 HOYER-HANSEN, G , LUND, IK , (2007) UROKINASE RECEPTOR VARIANTS IN TISSUE AND BODY FLUIDS.ADVANCES IN CLINICAL CHEMISTRY, VOL 44. VOL. 44. ISSUE . P. 65 -102 137 88% 40
10 SIDENIUS, N , BLASI, F , (2003) THE UROKINASE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER: RECENT ADVANCES AND IMPLICATION FOR PROGNOSIS AND THERAPY.CANCER AND METASTASIS REVIEWS. VOL. 22. ISSUE 2-3. P. 205-222 130 81% 259

Classes with closest relation at Level 1


Rank Class id link
1 34876 GLIOBLASTOMA CELL STRAIN//UPA PROMOTER//CELL CYCLE PREVALENCE
2 16953 PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2//PAI 2//SERPINB2
3 21510 ADMINISTRATION BY INHALATION//SPECIALTY CARE SERV//TEXAS LUNG INJURY
4 961 PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS
5 13770 NEUROSERPIN//TISSUE PLASMINOGEN ACTIVATOR//TISSUE TYPE PLASMINOGEN ACTIVATOR
6 2760 FIBRINOLYSIS//BM 06022//T PA VARIANTS
7 11860 STAPHYLOKINASE//PLASMINOGEN//STREPTOKINASE
8 19715 VITRONECTIN//KERCKHOFF KLIN HAEMOSTASIS UNIT//BIOL BUNKYO KU
9 37258 TOTAL PHOSPHATE EXTRACTION//CLIN ONCOL BRACHYTHER Y//TISSUE SPECIMENS
10 34382 TETRANECTIN//COILED COIL DOMAIN CONTAINING 3 GENE//FAVINE GENE

Go to start page